TEVA-CEFADROXIL 500 MG
CEFADROXIL (CEFADROXIL MONOHYDRATE) : 500 MG · DIN 02235134 · TEVA CANADA LIMITED
Health Canada status: MARKETED
What is TEVA-CEFADROXIL?
TEVA-CEFADROXIL 500 MG contains CEFADROXIL (CEFADROXIL MONOHYDRATE) : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02235134, held by TEVA CANADA LIMITED, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 17-Apr-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TEVA-CEFADROXIL used for?
TEVA – CEFADROXIL (cefadroxil) is indicated for the treatment of the following infections when caused by susceptible strains of the organisms indicated: • Acute uncomplicated urinary tract infections when caused by E.coli , Klebsiella species and some strains of Proteus mirabilis . • Skin and skin structure infections caused by Staphylococcus aureus and/or Group A ß – hemolytic streptococci. • Acute pharyngitis – tonsillitis, when caused by Group A ß – hemolytic streptococci.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is TEVA-CEFADROXIL called?
The same molecule, CEFADROXIL, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| RODAL | Latin | Morocco |
| BIODROXIL | Latin | Czechia, Morocco |
| ORACEFAL | Latin | Morocco |
| PREMOCEFAL | Latin | Morocco |
| Cefadroxil Viatris | Latin | Sweden |
| Cefadroxil Sandoz | Latin | Sweden |
| Dacef | Latin | South Africa |
| DURACEF | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02235134 |
|---|---|
| Brand name | TEVA-CEFADROXIL |
| Generic / active ingredient | CEFADROXIL (CEFADROXIL MONOHYDRATE) : 500 MG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 500 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01DB05 CEFADROXIL |
| AHFS class | 08:12.06.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 17-Apr-2012 |
| Original market date | 1999-06-02 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02235134 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2235134 |
| Brand name | TEVA-CEFADROXIL |
| Active ingredient / INN | CEFADROXIL (CEFADROXIL MONOHYDRATE) : 500 MG |
| ATC code | J01DB05 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01 |
| AHFS class | 08:12.06.04 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | TEVA CANADA LIMITED |
How is it stored and handled?
Store between 15° – 30°C. Protect from high humidity.
How is it supplied?
Bottles of 100 capsules.
Which pack is which?
| Strength on the label | 500 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
| Packaging as described in the monograph | Bottles of 100 capsules. |
| Storage | Store between 15° – 30°C. Protect from high humidity. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code J01DB05 CEFADROXIL. 3 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CEFADROXIL | 500 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02240774 |
| JAMP CEFADROXIL | 500 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02544792 |
| CEFADROXIL | 500 MG | CAPSULE | APOTEX INC | APPROVED | DIN 02240600 |
| DURICEF | 500 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 00507245 |
| PRO-CEFADROXIL - 500 | 500 MG | CAPSULE | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02311062 |
Who else supplies CEFADROXIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CEFADROXIL appears in 1353 registered pack listings across 7 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does CEFADROXIL cost around the world?
CEFADROXIL is listed on 8 national price registers Nexara tracks, across 74 pack listings published on 8 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 4 | 23 | 03 Sep 2026 |
| Morocco | PPV (public price) | 4 | 20 | 05 Sep 2026 |
| Saudi Arabia | public | 18 | 18 | 01 Sep 2026 |
| Sweden | AIP (pharmacy purchase price) | 2 | 4 | 03 Sep 2026 |
| Slovakia | categorised final price | 3 | 3 | 02 Sep 2026 |
| South Africa | single exit price | 3 | 3 | 01 Sep 2026 |
| Czechia | max producer price (ex-factory) | 2 | 2 | 03 Sep 2026 |
| Romania | max producer price | 1 | 1 | 03 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.